Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial

Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial

Summary: Background: The use of rosuvastatin plus colchicine and emtricitabine/tenofovir in hospitalized patients with SARS-CoV-2 disease (COVID-19) has not been assessed. The objective of this study was to assess the effectiveness and safety of rosuvastatin plus colchicine, emtricitabine/tenofovir...

Full description

Bibliographic Details
Main Authors: H.G. Gaitán-Duarte, MD MSc., C. Álvarez-Moreno, MD PhD., C.J. Rincón-Rodríguez, MSc., N. Yomayusa-González, MD., J.A. Cortés, MD., J.C. Villar, MD PhD., J.S. Bravo-Ojeda, MD., A. García-Peña, MD MSc., W. Adarme-Jaimes, PhD., V.A. Rodríguez-Romero, PhD., S.L. Villate-Soto, MSc., G. Buitrago, MD PhD., J. Chacón-Sarmiento, MD., M. Macias-Quintero, MSc., C.P. Vaca, MSc., C. Gómez-Restrepo, MD PhD., N. Rodríguez-Malagón, MPH.
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:EClinicalMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S258953702100523X

Internet

http://www.sciencedirect.com/science/article/pii/S258953702100523X

Similar Items